Trial Profile

A clinical trial to investigate ADX71441 for the treatment of cocaine use disorder

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 14 Jan 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ADX 71441 (Primary)
Indications Cocaine-related disorders
Focus Adverse reactions

Most Recent Events

07 Jan 2019 According to an Addex Therapeutics media release, the company plans to enter phase 1 trial during Q2 2019.
05 Oct 2017 New trial record
03 Oct 2017 According to an Addex Therapeutics media release, this trial will be conducted in coordination with the Friends Research Institute (FRI) and principal investigator, Dr. Frank J. Vocci. The studies are expected to begin in the first half of 2018.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com